CST3 and acute kidney injury: In recent decades, many specialists have attempted to identify ideal biomarkers to predict AKI, and an increasing number of novel biomarkers, such as kidney injury molecular-1 and cystatin C, have been investigated for their value in early AKI detection (12–14).